৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
In Women
Ovulation induction (with HCG after pituitary suppression)
Multi-follicular development during ART (IVF cycles)
Polycystic Ovarian Syndrome (PCOS)-related infertility
In Men
Induction of spermatogenesis in hypogonadotrophic-hypogonadism (with HCG)
Recombinant FSH produced via recombinant DNA technology in CHO cells.
Structure identical to natural human FSH.
Highly purified, consistent isoform profile, high biological activity.
Contains no LH activity.
Administered subcutaneously (SC), slowly to minimize pain and leakage.
Injection sites should be alternated.
Self-administration possible with proper training.
In Women
Ovulation induction: Start with 75 IU daily SC for 7 days, adjust by 25–75 IU weekly. Final maturation with 5000–10,000 IU HCG.
ART (IVF): Start with 150–300 IU daily SC for 4 days, adjust based on ultrasound/estradiol. Final maturation with HCG, oocyte retrieval after 34–36 hours.
PCOS: Start with 75 IU daily SC for 4–6 days, adjust cautiously (increments 75–300 IU).
In Men
Pre-treatment with HCG (2500–5000 IU twice weekly).
After testosterone normalization, add rFSH 300 IU per week SC (divided doses).
Tumors of ovary, breast, uterus, pituitary, hypothalamus
Pregnancy or lactation
Undiagnosed vaginal bleeding
Hypersensitivity to rFSH or excipients
Primary ovarian or testicular failure
Uterine fibroids incompatible with pregnancy
Ovarian hyperstimulation → pelvic pain, breathing problems, reduced urination
Rare: fluid in lungs, asthma worsening, blood clots, chest pain, severe abdominal pain, nausea, vomiting, sudden weight gain, bloating
May cause multiple births (twins, triplets)
Category X: Contraindicated during pregnancy and lactation.
Exclude uncontrolled endocrine disorders (thyroid, adrenal, pituitary).
Increased risk of multiple gestations and ectopic pregnancy in ART.
Higher pregnancy loss rates in ART compared to normal population.
Monitor estradiol and follicular growth to avoid ovarian hyperstimulation syndrome (OHSS).
First injection should be under medical supervision.
In men, semen analysis recommended after 4–6 months.
No human acute toxicity data.
Excess dose may cause ovarian hyperstimulation.
Drugs for infertility, trophic hormones & related synthetic drugs.
Add 1 ml water for injection to vial of 75 IU rFSH.
Swirl gently until clear.
Up to 3–4 vials can be reconstituted together for higher doses.




N/A
N/A



